NEMF

Across TCGA pan-cancer cohorts, NEMF mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated NEMF data layer compared with 26 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher NEMF mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated NEMF expression acts as an unfavorable survival marker, although some lineages such as HNSC and PDAC show a favorable association.

HNSC, LUAD, and GBM are the cancer types where NEMF mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	All	0.855	0.644	.019	9	view →
LUAD	OS	Quartile	III,IV	0.509	0.889	.020	7	view →
GBM	DFS	Tertile	All	0.232	0.555	.002	6	view →
PDAC	OS	Quartile	III,IV	0.971	0.488	.040	6	view →
LSCC	DFS	Median	II,III,IV	0.485	1.000	.006	5	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

NEMF–HNSC (DFS)

Open the HNSC breakdown →